Pancreatic Cancer Research

ResearcherNanjing University of Chinese MedicineNo recent work listed

Xin Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-5232-327X; OpenAlex author ID A5101424607. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2021: 2 papers

Papers 2

  1. Arl4c promotes the growth and drug resistance of pancreatic cancer by regulating tumor-stromal interactions. Co-author DOI 10.1016/j.isci.2021.103400↗
  2. Serum Exosomal miRNA-1226 as Potential Biomarker of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.2147/ott.s296816↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Wei Li · 1 shared paper, 2021 · strength 0.13
  2. Zheng Wang · 1 shared paper, 2021 · strength 0.13
  3. Qingyong Ma · 1 shared paper, 2021 · strength 0.13
  4. Cheng Wang · 1 shared paper, 2021 · strength 0.13
  5. Zheng Wu · 1 shared paper, 2021 · strength 0.13
  6. Liang Han · 1 shared paper, 2021 · strength 0.13
  7. Xiao Chen · 1 shared paper, 2021 · strength 0.13
  8. Weikun Qian · 1 shared paper, 2021 · strength 0.13
  9. Yongkang Liu · 1 shared paper, 2021 · strength 0.13
  10. Wanxing Duan · 1 shared paper, 2021 · strength 0.13
  11. Jianhua Wang · 1 shared paper, 2021 · strength 0.13
  12. Zhongqiu Wang · 1 shared paper, 2021 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.